Shikonin Inhibits Intestinal Calcium-Activated Chloride Channels and Prevents Rotaviral Diarrhea by Yu Jiang et al.
fphar-07-00270 August 19, 2016 Time: 18:44 # 1
ORIGINAL RESEARCH
published: 23 August 2016
doi: 10.3389/fphar.2016.00270
Edited by:
Raffaele Capasso,
University of Naples Federico II, Italy
Reviewed by:
Martin Diener,
University of Giessen, Germany
Surjit Kaila Singh Srai,
University College London, UK
*Correspondence:
Hong Yang
hyanglnnu@126.com
Tonghui Ma
tonghuima@dlmedu.edu.cn
Specialty section:
This article was submitted to
Gastrointestinal and Hepatic
Pharmacology,
a section of the journal
Frontiers in Pharmacology
Received: 24 May 2016
Accepted: 10 August 2016
Published: 23 August 2016
Citation:
Jiang Y, Yu B, Yang H and Ma T
(2016) Shikonin Inhibits Intestinal
Calcium-Activated Chloride Channels
and Prevents Rotaviral Diarrhea.
Front. Pharmacol. 7:270.
doi: 10.3389/fphar.2016.00270
Shikonin Inhibits Intestinal
Calcium-Activated Chloride
Channels and Prevents Rotaviral
Diarrhea
Yu Jiang1, Bo Yu1, Hong Yang1* and Tonghui Ma2*
1 Liaoning Provincial Key Laboratory of Biotechnology and Drug Discovery, School of Life Sciences, Liaoning Normal
University, Dalian, China, 2 College of Basic Medical Sciences, Dalian Medical University, Dalian, China
Secretory diarrhea remains a global health burden and causes major mortality in
children. There have been some focuses on antidiarrheal therapies that may reduce
fluid losses and intestinal motility in diarrheal diseases. In the present study, we
identified shikonin as an inhibitor of TMEM16A chloride channel activity using cell-
based fluorescent-quenching assay. The IC50 value of shikonin was 6.5 µM. Short-
circuit current measurements demonstrated that shikonin inhibited Eact-induced Cl−
current in a dose-dependent manner, with IC50 value of 1.5 µM. Short-circuit
current measurement showed that shikonin exhibited inhibitory effect against CCh-
induced Cl− currents in mouse colonic epithelia but did not affect cytoplasmic Ca2+
concentration as well as the other major enterocyte chloride channel conductance
regulator. Characterization study found that shikonin inhibited basolateral K+ channel
activity without affecting Na+/K+-ATPase activities. In vivo studies revealed that shikonin
significantly delayed intestinal motility in mice and reduced stool water content in a
neonatal mice model of rotaviral diarrhea without affecting the viral infection process
in vivo. Taken together, the results suggested that shikonin inhibited enterocyte calcium-
activated chloride channels, the inhibitory effect was partially through inhbition of
basolateral K+ channel activity, and shikonin could be a lead compound in the treatment
of rotaviral secretory diarrhea.
Keywords: CaCC, TMEM16A, inhibitor, shikonin, short-circuit current, rotaviral diarrhea
INTRODUCTION
Secretory diarrhea remains a global health burden and causes major mortality in children under
5 years old (Walker et al., 2013). Repeated diarrhea leads to malnutrition, growth retardation,
physical and mental impairment (Petri et al., 2008). Major causes of infectious secretory diarrhea
include bacteria such as Vibrio cholerae and enterotoxigenic Escherichia coli, and viruses such as
rotavirus and norovirus as well as some parasites (Walker et al., 2013). Chloride channels located
in the luminal membrane of enterocytes represent a significant target for the treatment of secretory
diarrhea, because over activation of these channels can cause the massive secretion of chloride ions
into the intestinal lumen, and consequently creates an electrochemical gradient and an osmotic
force to drive the secretion of sodium and water (Barrett and Keely, 2000). Increased intestinal
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motility is one of the features in some diarrheal diseases. One
of the major chloride channels, cystic fibrosis transmembrane
conductance regulator (CFTR), has been shown to be responsible
for the enterotoxin-induced secretory diarrhea in cholera and
Travelers’ diarrhea (Chao et al., 1994; Grubb, 1995; Thiagarajah
et al., 2004; Sonawane et al., 2007). Another enterocyte chloride
channel, calcium-activated chloride channels (CaCCs), is thought
to be associated with rotavirus-induced and probably other virus-
related secretory diarrhea (Morris et al., 1999). TMEM16A was
the first CaCC protein that was discovered (Caputo et al., 2008;
Schroeder et al., 2008; Yang et al., 2008), and it was found
expressed abundantly in the interstitial cells of Cajal (ICC),
generating smooth muscle contraction (Huang et al., 2009;
Hwang et al., 2009; Ferrera et al., 2010). In rotaviral diarrhea,
it is considered that a non-structural protein NSP4 activates
TMEM16A/CaCC in the enterocytes (Ball et al., 1996; Morris
et al., 1999), but the exact mechanism of this remains to be
elucidated.
Apart from TMEM16A, the identities of other gastrointestinal
CaCCs (CaCCGI) remain unclear. Accumulated evidence show
that CaCCs contributes to chronic constipation (Jiang et al.,
2015), hypertension (Wang et al., 2015), tumor (Huang et al.,
2002; West et al., 2004; Carles et al., 2006), and diarrhea (Ko et al.,
2014). Specific inhibitors against CaCCs have been identified, and
these have been proven effective at reducing watery stools in a
neonatal mice model of secretory diarrhea (Ko et al., 2014). In
our previous study, we showed that the anti-diarrheal activity of
the traditional Chinese medicine Bistortae Rhizoma is due to its
inhibition of CFTR- and CaCC-mediated secretion of Cl− ions
from intestinal epithelia, and delaying gastrointestinal motility
(Yu et al., 2015). There has been some focus on antisecretory
therapies aiming at reducing fluid losses and intestinal motility
(Donowitz et al., 2012). The present study aimed at identifying
new small molecule inhibitors that could inhibit TMEM16A or
CaCCGI chloride channels in order to reduce intestinal motility
and fluid secretion. This was conducted as part of the effort to
search for potentially new therapeutic antidiarrheal drugs.
MATERIALS AND METHODS
Cell Lines, Animals, Virus, and Chemicals
Fischer rat thyroid epithelial (FRT) cells co-expressing
TMEM16A and the halide sensor YFP-H148Q/I152L were
cultured in F12 coon’s medium (Sigma Chemical Co. St. Louis,
MO, USA) supplemented with 10% fetal bovine serum (HyClone
company, USA), 100 U/mL penicillin, 100 µg/mL streptomycin
and 2 mM L-glutamine. HT-29 cells were cultured in RPMI
1640 medium (Sigma Chemical Co. St. Louis, MO, USA)
supplemented with 10% fetal bovine serum (HyClone company,
USA), 100 u/mL penicillin, 100 µg/mL streptomycin and 2 mM
L-glutamine. Cells were incubated at 37◦C in the presence of
5% CO2 and 95% humidity air. SA-11 rotavirus was a gift from
Professor Verkman in UCSF.
ICR mice (8–10 weeks) were kept with a standard chew diet
under specific pathogen-free conditions in a natural day/night
circle at Dalian Medical University (Permit Number: SCXK liao
2008-0002). All experiments were carried out in accordance with
the Guide for the Care and Use of Laboratory Animals of the
National Institutes of Health, and were approved by the Liaoning
Normal University Committee on Animal Research.
CFTRinh-172 was synthesized as described previously (Garcia
et al., 2009). The specific TMEM16A activator Eact and CaCC
inhibitor CaCCinh-A01 were bought from Chembest Research
Laboratory Limited (Shanghai). ATP and NaI were purchased
from Sangon Biotech (Shanghai) Co., Ltd. Carbachol (CCh)
was purchased from EDM Chemicals, Inc. (San Diego, CA,
USA). Fluo-4 NW was purchased from Invitrogen (Invitrogen,
Carlsbad, CA, USA). Amphotericin B was purchased from
Solarbio (Beijing Solarbio Science & Technology Co., Ltd).
T16Ainh-A01 was a generous gift from Professor Verkman at
UCSF. Other chemicals, unless indicated otherwise, were all
purchased from Sigma (Sigma Chemical Co, St. Louis, MO,
USA).
Iodide Influx Fluorescent Assay
To measure the inhibition of TMEM16A by shikonin, FRT
cells expressing TMEM16A were seeded in a black walled clear
bottom 96 well plate (Costar, Corning, NY, USA) until confluent.
The cells were then washed three times with PBS followed
by incubation with different concentrations of shikonin for
10 min. Fluorescence data were recorded with a FLUOstar Galaxy
microplate reader (BMG Lab Technologies, Inc.) equipped
with HQ 535/30M (535 ± 15 nm) emission and HQ500/20X
(500 ± 10 nm) excitation filters (Chroma Technology Corp.),
and syringe pumps. Fluorescence was recorded continuously for
14 s, and ATP (200 µM) were pumped into the system along
with iodide at 2 s. Iodide influx rates (d[I–]/dt) were computed
as described in previous study (Kristidis et al., 1992).
Intracellular Calcium Measurements
HT-29 cells were seeded in a 96-well black-walled microplate,
and incubated until confluent. The cells were washed with PBS
three times, and then incubated with Fluo-4 NW according
to the manufacturer’s protocol for 15 min. Fluo-4 fluorescence
was measured with a FLUOstar Optima fluorescence plate
reader equipped with syringe pumps and custom Fluo-4
excitation/emission filters (485/538 nm).
Short-Circuit Current
Fischer rat thyroid epithelial cells expressing TMEM16A were
plated in snapwell inserts and allowed to grow until 95%
confluent. Snapwell inserts were mounted in Ussing chambers
(Physiological Instruments, San Diego, CA, USA) connected to a
VCC MC 6 multi-channel voltage-current clamp via silver/AgCl
electrodes with 3 M KCl agar bridges. FRT cell monolayers were
stabilized for 30-min in half-Cl− solution (apical, containing
in mM: 65 NaCl, 65 Na Gluconate, 2.7 KCl, 1.5 KH2PO4, 0.5
MgCl2, 2 CaCl2, 10 Hepes, 10 Glucose, pH 7.4.) and HCO3−
buffered solution (basolateral, containing in mM: 130 NaCl, 2.7
KCl, 1.5 KH2PO4, 0.5 MgCl2, 2 CaCl2, 10 Hepes, 10 Glucose, pH
7.4.). After that, the cells were permeablized basolaterally with
amphotericin B (250 mg/L) before activation by Eact.
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Male ICR mice were killed by an overdose of intraperitoneal
injection of sodium pentobarbital (100 mg/kg). The colon was
removed from each animal and washed with ice-cold modified
KH solution (containing in mM: 120 NaCl, 5 KCl, 1 MgCl2, 1
CaCl2, 10 D-glucose, 5 Hepes, 25 NaHCO3, 10µM indomethacin,
pH 7.4.). It was then mounted in Ussing Chambers after stripping
off the muscularis. The hemi-chambers were each filled with
5 mL KH solution bubbled with 95% O2/5% CO2 at 37◦C.
Indomethacin (10 µM) was added into both hemi-chambers to
prevent prostaglandin generation. Amiloride (10 µM) was added
to the mucosal side to inhibit epithelial Na+ current.
For the measurement of apical membrane Cl− current, the
basolateral membrane was depolarized with a high potassium
concentration solution. After more than 40 min, apical Cl−
current was measured in the presence of a serosal-to-mucosal Cl−
gradient. The apical solution contains (in mM): 107 K-gluconate,
4.5 KCl, 25 NaHCO3, 1.8 Na2HPO4, 0.2 NaH2PO4, 5.75 Ca-
gluconate, 1.0 MgSO4 and 12 D-glucose. The basolateral solution
contains (in mM): 111.5 KCl, 25 NaHCO3, 1.8 Na2HPO4, 0.2
NaH2PO4, 1.25 CaCl2, 1.0 MgSO4, and 12 D-glucose.
For basolateral K+ current measurement, the colonic tissues
were placed in a modified KH solution, the apical solution
contains (in mM): 116 K-gluconate, 4.7 KCl, 5 CaCl2, 1.2 MgCl2,
NaHCO3, 1.2 KH2PO4, 11.1 D-glucose. The basolateral solution
contains (in mM): 116 Na-gluconate, 4.7 KCl, 5 CaCl2, 1.2 MgCl2,
NaHCO3, 1.2 KH2PO4, 11.1 D-glucose. 100 µM ouabain was
added to the basolateral solution to inhibit Na+–K+-ATPase.
Subsequent permeabilization of the apical membrane was with
nystatin (200 µg/mL).
In the measurement of Na+/K+-ATPase activity, the mucosal
side of the tissue was permeablized with nystatin (200 µg/mL).
All cells and tissues were aerated with 95% O2/5% CO2
at 37◦C during the experiments. Transepithelial short-circuit
currents were recorded by Acquire and Analyze 2.3 software,
transepithelial potential was clamped at 0 mV during the whole
processes mentioned above.
Intestinal Motility Measurement
ICR mice were starved for 24 h and then orally administered
shikonin (5.8 µg). After 30 min, 20 mg of 10% activated charcoal
diluted in 5% gum arabic was administered orally. After another
30 min, the animals were sacrificed and the small intestines were
removed. Peristaltic index was calculated as the ratio of the length
that activated charcoal had traveled to the total length of the small
intestine.
Mouse Model of Rotaviral Diarrhea
Neonatal ICR mice (age 4–7 days, weight 2–3 g) were inoculated
with 30µL rotavirus (virus titer 1.2× 107 pfu/mL) by oral gavage
using a polyethylene tube (0.6 mm outer diameter, 0.3 mm inner
diameter) and an insulin syringe. The mice were then returned to
their mothers and allowed to suckle. Stool samples were collected
daily by gentle palpation of the abdomen. In one set of the
experiments, the shikonin-treated group received shikonin orally
(0.4 and 1.7 µg in 30 µL PBS) the day before virus inoculation,
and three times a day until day 3. Control mice received 30 µL
PBS alone. The positive control (CaCCinh-A01) mice received
34 µg (in 20 µL PBS) CaCCinh-A01 by intraperitoneal injection
on the day before virus inoculation and twice a day thereafter
until day 3. In another set of experiments, shikonin-treated group
received shikonin in PBS on the next day of virus inoculation,
and three times a day until day 3. Negative control mice received
30 µL PBS alone. The positive control mice received CaCCinh-
A01 by intraperitoneal injection the day before virus inoculation
and twice a day thereafter until day 3.
Stool Water Content Analysis
To collect the stool samples, the abdomen of the animal was
gently palpated. To quantify the water content in the stool, a
polymethyl methacrylate (PMMA) slab of 2.0 mm thickness was
used in which a 1.0-mm diameter hole was punched to contain
a cylindrical 1.57 mm3 volume of stool. The cylindrical stool
plug was deposited onto a piece of cellulose acetate membrane
(saturated with 0.1% neutral red, then dried) and allowed to
contact the paper for 3 min in a humidified atmosphere. The
wetted area was quantified by digital imaging.
Histology
Mice were sacrificed on day 3, and the ileum were isolated and
rinsed with PBS. Specimens were fixed with formalin for 24 h,
and then embedded in paraffin, and stained with haematoxylin
and eosin.
Statistical Analysis
All data were expressed as mean± SE or as representative traces.
One-way or two-way ANOVA followed by Dunnett’s multiple
comparison test was used to compare test and control values, and
statistically significances were considered at the p< 0.05 level.
Ethics Statement
This study was carried out in accordance with the
recommendations of “Guide for the Care and Use of Laboratory
Animals of the National Institutes of Health” and were approved
by the Liaoning Normal University Committee on Animal
Research. All surgery was performed under sodium pentobarbital
anesthesia, and possible efforts were made to minimize suffering.
RESULTS
Identification of Shikonin as TMEM16A
Chloride Channel Inhibitor
TMEM16A was the first CaCC identified, and the effect
of shikonin (Figure 1A) on TMEM16A chloride channel
activity was studied using a previously set up cell-based
fluorescent quenching assay. Short-circuit current measurements
were performed in FRT cells expressing TMEM16A. Shikonin
inhibited ATP-stimulated TMEM16A chloride channel activity
with an IC50 value of 6.5 µM (Figure 1B). Short-circuit
current measurement showed that inhibition of TMEM16A
chloride currents by shikonin was concentration-dependent, and
the highest concentration (10 µM) of shikonin used could
only abolish about 65% of the Cl− current stimulated by
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FIGURE 1 | Inhibition of TMEM16A chloride channel activities by shikonin. (A) Structure of shikonin. (B) Fluorescence quenching assay showing the inhibition
of TMEM16A chloride channel activity by different concentrations of shikonin. (C) Partial inhibition of Eact-induced TMEM16A-mediated short-circuit currents by
shikonin and T16Ainh-A01. (D) Histogram compares the magnitude of Eact-induced short-circuit currents inhibited by shikonin and T16Ainh-A01. The traces shown
are typical results from three independent experiments.
Eact (Figure 1C). On the other hand, T16Ainh-A01 (30 µM)
completely inhibited Eact-induced TMEM16A-mediated short-
circuit current (Figure 1D).
Shikonin Inhibits CCh-Induced
Short-Circuit Currents in Adult Mouse
Colonic Epithelium
The efficacy of inhibition exerted by shikonin on endogenous
gastrointestinal CaCC (CaCCGI) of mouse colon was
investigated. Different concentrations of shikonin were added
to the mucosal solution, and 15 min later short-circuit currents
were stimulated by cholinergic agonist carbachol. Inhibition of
CaCCGI current by shikonin was concentration dependent, with
5 and 20 µM shikonin reduced the currents by 24 ± 8.7 and
48 ± 10.7%, respectively (Figure 2A), and this was better than
the inhibition exerted by 50 µM CaCCinh-A01 (34± 8.8%).
Since CaCCs can be activated by increases in cytoplasmic
calcium concentration, we therefore measured the calcium
concentration following activation by ATP. It appeared that ATP-
induced cytoplasmic calcium concentration was not affected by
5 µM shikonin (Figure 2B).
To exclude the possibility that the reduced transepithelial
currents caused by shinkonin were due to inhibition of
K+ transport, transepithelial currents were measured under
depolarization condition. Experiments were performed under
the condition that the basolateral membrane was depolarized
by high concentration of K+. The results indicated that apical
application of shikonin (20 µM) and the CaCC specific inhibitor
CaCCinh-A01 (50 µM) still could reduce CCh-induced short-
circuit currents by 27.8 ± 2.7 and 30.5 ± 3.3%, respectively,
as compared to the DMSO control (Figure 2C), suggesting that
shikonin directly inhibited chloride currents.
The efficacy of shikonin-mediated inhibition of CFTR chloride
channel activity was also tested ex vivo in freshly isolated
mouse colonic mucosa. Short-circuit currents were stimulated
by FSK (20 µM), and then shikonin (2–50 µM) was added
into the mucosal or serosal solution to investigate the inhibitory
effect of shikonin on FSK-stimulated CFTR-mediated Cl−
current. Shikonin did not affect CFTR-mediated short-circuit
currents in mouse colonic epithelia (Figure 2D). The remaining
currents were abolished by CFTRinh-172 (100 µM). These results
suggested that shikonin directly inhibited CaCCGI chloride
activity in mouse colonic epithelia.
Characterization of Shikonin-Inhibited
CaCC Currents
Apical secretion of Cl− in the enterocyte requires the driving
force provided by Na+/K+-ATPase, Na+/K+/2Cl− cotransporter
and K+ channels located in the basolateral membrane. Thus
inhibition of these transporters will indirectly lead to reduced
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FIGURE 2 | Effect of shikonin on Cl− transport in mouse colonic epithelium. (A) Inhibition of CCh-induced short-circuit currents by DMSO, shikonin (5 and
20 µM) and CaCCinh-A01 (n = 3). The plot compares the magnitude of inhibition seen in the chart. Data are the means ± SEs of three independent tests ∗p < 0.05.
(B) Cytoplasmic Ca2+ measured by Fluo-4 NW fluorescence under basal conditions following the addition of ATP (100 µM). HT-29 cells were pretreated with DMSO
or 5 µM shikonin. (C) Inhibition of apical Cl− current by DMSO, shikonin (20 µM) and CaCCinh-A01 (50 µM) (n = 3). Summary of ICl is shown in the right panel. The
plot compares the magnitude of inhibition seen in the chart. Data are the means ± SEs of three independent tests ∗p < 0.05. (D) Effect of shikonin on CFTR chloride
channel activity in mouse colonic epithelium. CFTRinh-172 was used to abolish FSK-induced short-circuit currents. The traces shown are typical results from three
independent experiments.
FIGURE 3 | Characterization of shikonin-inhibited CaCC currents. (A) Inhibition of basolateral K+ channel by DMSO, shikonin (20 µM) and clotrimazole
(50 µM). Summarized IK is shown in the right panel. The plot compares the magnitude of inhibition seen in the chart. Data are the means ± SEs of three
independent tests ∗∗p < 0.01, ∗∗∗p < 0.0005. (B) Effect of shikonin on Na+/K+-ATPase in mouse colonic epithelium. Short-circuit current was induced by
intracellualr Na+ loading following mucosal permeabilization by nystatin (200 µg/mL). The traces shown are typical results from three independent experiments.
apical chloride secretion in the enterocyte. We therefore analyzed
the effect of shikonin on basolateral K+ channel and Na+/K+-
ATPase in mouse colonic epithelia. As seen in Figure 3A,
after permibilization of apical membrane by nystatin, shikonin
decreased CCh-stimulated short-circuit current by 55.0 ± 4.3%
compared to DMSO control, whereas the basolateral K+ channel
inhibitor clotrimazole decreased the current by 82.5 ± 2.8%,
suggesting that shikonin significantly inhibited Ca2+-activated
basolateral K+ channel. To measure the activity of Na+/K+-
ATPase, short-circuit current was analyzed after mucosal
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FIGURE 4 | Inhibition of gastrointestinal motility by shikonin.
(A) Photographs of isolated mouse intestinal tracts showing the distance
traveled by activated charcoal after administration of PBS or shikonin by oral
gavage. (B) Comparison of the peristaltic indexes (distances activated carbon
moved in the intestines) between PBS- and shikonin-treated animals. Data are
the means ± SEs of three independent experiments. ∗∗Significantly different
from PBS-treated animal at the p < 0.01 level.
permeabilization and addition of different concentrations (5–
50 µM) of shikonin to the serosal solution. As shown in
Figure 3B, shikonin had no effect on Na+/K+-ATPase-mediated
short-circuit current, and the nystatin-stimulated currents were
completely abolished by the Na+/K+-ATPase inhibitor ouabain
(500 µM), suggesting that inhibition of chloride transport by
shikonin was not via inhibition of basolateral Na+/K+-ATPase
activities.
Inhibition of Adult Mouse Intestinal
Motility by Shikonin
Enhanced intestinal motility is also a symptom in some
infectious diarrhea. TMEM16A is expressed abundantly in the
ICC where it generates smooth muscle contraction, thereby
mediates gastrointestinal motility (Huang et al., 2009; Hwang
et al., 2009; Ferrera et al., 2010). Therefore the effect of shikonin
on gastrointestinal motility was investigated (Figure 4A). Oral
administration of 5.8 µg shikonin significantly reduced intestinal
peristalsis and delayed charcoal movement in mice, yielding a
peristaltic index of 34.9 ± 9.1%, compared to 82.3 ± 2.9%
induced by PBS (Figure 4B).
Shikonin Prevents Watery Stools in
Rotavirus Infected Neonatal Mice
The inhibitory effect of shikonin on rotaviral diarrhea in vivo
was tested with two protocols as described above. Figure 5A
(top) shows the first protocol used to induce rotaviral diarrhea
in neonatal mice. Grossly watery stools started on day 1
after rotavirus inoculation, and it lasted for the next 3 days.
Comparison of the images of the cellulose acetate membrane
taken 3 min after the deposition of the stools with those taken
after the removal of the stools showed the wetted area (marked by
thin broken circular lines) varied among the different treatments
over the 3 days (Figure 5A bottom). The water content decreased
in shikonin- and CaCCinh-A01-treated groups, as shown by the
smaller wetted area. Figure 5B compares the wetted area left
by the stools on days 1–3 from mice treated with shikonin
or CaCCinh-A01. In the second protocol, shikonin was also
effective when administered on day 1, after watery diarrhea had
FIGURE 5 | Effect of shikonin on rotaviral diarrhea in a neonatal mouse
model. (A) Schematic illustration of the protocol used to induce rotaviral
diarrhea in mice and the image of the stools obtained from these animals.
Mice were orally given a single dose of shikonin (0.4 and 1.7 µg) the day
before rotavirus inoculation, and three doses per day for the next 4 days.
Positive control mice were intraperitoneal injected with a single dose (34 µg)
of CaCCinh-A01 the day before rotavirus inoculation followed by two doses
per day for the next 4 days. Photographs of the cellulose acetate membranes
taken 3 min after deposition of the stool specimens (left) and after removal of
the stool specimens (right). Wetted area is demarcated by the broken line.
(B) The plots compare the size of the wetted area on the cellulose acetate
membrane after removal of the stools. (C) Similar study as in (A), except that
shikonin gavage started on day 1(SE, n = 4–6 mice). Data are the
means ± SEs of three independent experiments. Significant difference
between rotavius-inoculated group (a) and shikonin-(b and c) or CaCCinh-A01
(d)-treated groups (p < 0.0005).
begun, with significantly lower water content in the stools on
days 2–3 (Figure 5C). These results demonstrated that shikonin
could prevent water diarrhea following rotavirus inoculation
in neonatal mice, and the effect was better than CaCCinh-
A01.
Shikonin Does Not Inhibit Rotavirus
Infection
Rotavirus infection of the intestine was further verified by
histology, which revealed marked vacuolization of enterocytes
in the infected animals. Three days after infection, villus
tip swelling and large vacuoles were seen in enterocytes
lining in the surface of villi in the rotavirus-infected groups
(Figure 6). Vacuoles were not seen in the non-infected
mice. Shikonin-treated mice also showed vacuolization
similar to that in the untreated rotavirus-infected mice,
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FIGURE 6 | Effect of shikonin on rotavirus infection in neonatal mice model. Histological analysis of mouse ileum on day 3 of the infection. Images shown are
photographs taken of paraffin-embedded sections from control mice, rotavirus-inoculated control and shikonin-treated mice.
supporting the conclusion that shikonin reduced water diarrhea
through antisecretory action rather than preventing rotavirus
infection.
DISCUSSION
Viral diarrhea remains one of the most fatal diseases in
children in both developed and developing countries. The
present study found that shikonin inhibited TMEM16A and
CaCCGI in the intestine, and significantly reduced intestinal
motility in mice and stool water content in a neonatal mice
model following rotavirus infection. Shikonin was inhibitory
against CaCC-mediated colonic epithelial Cl− transport in
isolated mouse colon. Unlike tannic acid and gallotannins,
which also inhibits another major enterocyte chloride channel,
CFTR or ENaC (Namkung et al., 2010), shikonin was not
inhibitory toward CFTR or Na+/K+-ATPase, thus displaying
stronger selectivity for the inhibition of CaCC chloride channel
activity than tannic acid and gallotannins. However, it is
important to note that neither shikonin nor CaCCinh-A01
could completely inhibit CCh-stimulated short-circuit currents
in isolated mouse colon. Basolateral Ca2+-activated K+ channels
have been shown to express in human and mouse colon
(Rufo et al., 1996, 1997; Sandle and Rajendran, 2012). Ourt
study didn’t ignore the possibility of indirect inhibitory
effect of shikonin via basolateral K+ channel. As assumed,
basolateral Ca2+-activated K+ channel did account, at least a
part, for the inhibition of CCh-induced chloride current by
shikonin.
Reduction of stool water content in rotaviral neonatal mice
by shikonin observed in this study probably occurred via an
anti-secretory action of shikonin, which involved inhibition of
CaCCGI chloride channel activity. Although TMEM16A exists
in enterocytes, some investigators have proposed that secretory
diarrhea caused by the rotaviral non-structural protein NSP4 is
predominantly through the activation of epithelial TMEM16A in
the intestine. One study that used the small molecule TMEM16A
inhibitor T16Ainh-A01 has demonstrated that TMEM16A
constitutes only a minor component of the intestinal epithelial
CaCC (Namkung et al., 2011). Our previous work has shown
that TMEM16A and CaCCGI have different characteristics,
since the lignan compounds kobusin and eudesmin can affect
TMEM16A and CaCCGI differently, inhibiting TMEM16A, while
activating CaCCGI, (Jiang et al., 2015). We have shown in this
study that shikonin was inhibitory toward CaCCGI-mediated
short-circuit currents in both cell culture model and isolated
mouse colon. In addition, in vivo studies showed that shikonin
reduced water content in a neonatal mice diarrhea model
without affecting the rotavirus infection process (Figure 6).
These findings supported the view that the primary pathway of
watery diarrhea associated with rotaviral infection is through
activation of CaCCGI rather than TMEM16A by NSP4, thereby
enhancing the accumulation of fluid. Furthermore, inhibition of
TMEM16A by shikonin delayed gastrointestinal motility, helping
to prolong the fluid absorption time to further decrease net fluid
secretion.
As the major component of Zicao, the dried root of
Lithospermum erythrorhizon, shikonin has been broadly used due
to its anti-inflammatory activity (Chen et al., 2002). Shikonin
has been reported to have antioxidant, antibacterial, antiparasitic,
antiviral and wound-healing activities (Andujar et al., 2013).
Shikonin might be used in the treatment of asthma. Takano-
Ohmuro et al. (2008) has explored the use of shikonin in asthma
by focusing on its anti-inflammatory activity (Takano-Ohmuro
et al., 2008). Other investigators have used a mouse asthma
model to demonstrate that shikonin inhibits bone marrow-
derived dendritic cell maturation in vitro, and allergic action as
well as tracheal hyperresponsiveness in vivo (Lee et al., 2010).
Since TMEM16A is expressed in airway smooth muscle cells
and it participates in smooth muscle contraction (Huang et al.,
2012), we assumed that TMEM16A may be involved in shikonin-
mediated inhibition of asthma. In our study, shikonin was found
to inhibit TMEM16A chloride channel activity, indicating that
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shikonin might alleviate asthma by inhibiting smooth muscle
contraction in the trachea.
Despite the many positive benefits of shikonin, it is not
without toxicity. Intraperitonal injection of shikonin has been
demonstrated to result in some toxicity, with an LD50 of
20 mg/kg (Sankawa et al., 1977). Pharmacokinetics study has
shown that shikonin absorption is fast if given by oral gavage
and muscle injection, as it is barely detected in the plasma after
1 min, with a oral gavage yielding a bioavailability of about
34% (Wang et al., 1988). In this study, the doses used for
intestinal motility (0.38 mg/kg) and rotaviral infection in the mice
model (0.69 mg/kg) were below the doses that are considered as
toxic.
CONCLUSION
The present study revealed shikonin as a new inhibitor against
TMEM16A and CaCCGI chloride channel, adding to the list of
biological activities that this compound already possesses, and
showed that shikonin could be leading drug in the treatment of
rotaviral diarrhea.
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